Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Ihl

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Pharmacopsychiatry|September 18, 2003
The impact of drugs against dementia on cognition in aging and mild cognitive impairmentR Ihl
MMW Fortschritte Der Medizin|June 10, 2009
[Challenging pharmacotherapy in dementia]R Ihl
MMW Fortschritte Der Medizin|June 20, 2002
[Dementing disorders. What benefits do the new anti-dementia drugs have?]R Ihl
Der Nervenarzt|September 11, 1998
[Nootropic drug evaluation for general practice]R Ihl, C Kretschmar
Dementia and Geriatric Cognitive Disorders|February 23, 1999
Differential diagnosis of aging, dementia of the Alzheimer type and depression with EEG-segmentationR Ihl, J Brinkmeyer
Journal of the Neurological Sciences|September 15, 2010
Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trialR Ihl, M Tribanek, N Bachinskaya
Psychiatry Research|September 1, 1989
The effect of pyritinol upon P300 topographyK Maurer, T Dierks, R Ihl
Fortschritte Der Neurologie-Psychiatrie|September 1, 1994
[Dementia and disorders of the thyroid gland]E Hobik, R Ihl, C Kretschmar
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1993
Age-related changes of spontaneous EEG described by equivalent dipolesT Dierks, R Ihl, K Maurer
Pharmacopsychiatry|November 17, 2011
Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trialR Ihl, M Tribanek, N Bachinskaya, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Pharmacopsychiatry|September 18, 2003
The impact of drugs against dementia on cognition in aging and mild cognitive impairmentR Ihl
MMW Fortschritte Der Medizin|June 10, 2009
[Challenging pharmacotherapy in dementia]R Ihl
MMW Fortschritte Der Medizin|June 20, 2002
[Dementing disorders. What benefits do the new anti-dementia drugs have?]R Ihl
Der Nervenarzt|September 11, 1998
[Nootropic drug evaluation for general practice]R Ihl, C Kretschmar
Dementia and Geriatric Cognitive Disorders|February 23, 1999
Differential diagnosis of aging, dementia of the Alzheimer type and depression with EEG-segmentationR Ihl, J Brinkmeyer
Journal of the Neurological Sciences|September 15, 2010
Baseline neuropsychiatric symptoms are effect modifiers in Ginkgo biloba extract (EGb 761®) treatment of dementia with neuropsychiatric features. Retrospective data analyses of a randomized controlled trialR Ihl, M Tribanek, N Bachinskaya
Psychiatry Research|September 1, 1989
The effect of pyritinol upon P300 topographyK Maurer, T Dierks, R Ihl
Fortschritte Der Neurologie-Psychiatrie|September 1, 1994
[Dementia and disorders of the thyroid gland]E Hobik, R Ihl, C Kretschmar
International Journal of Psychophysiology : Official Journal of the International Organization of Psychophysiology|November 1, 1993
Age-related changes of spontaneous EEG described by equivalent dipolesT Dierks, R Ihl, K Maurer
Pharmacopsychiatry|November 17, 2011
Efficacy and tolerability of a once daily formulation of Ginkgo biloba extract EGb 761® in Alzheimer's disease and vascular dementia: results from a randomised controlled trialR Ihl, M Tribanek, N Bachinskaya, et al.
Pageof 5